Quantcast

Latest Angiogenesis Stories

2011-06-22 08:00:00

SAN DIEGO, June 22, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced the selection of the Cedars-Sinai Medical Center Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los Angeles, California, to serve as the central core lab for the Company's Generx ASPIRE clinical study. Cedars-Sinai Core Laboratory will be responsible for the consolidation and analysis of SPECT (single-photon emission computed tomography) myocardial imaging data from the...

2011-06-17 06:05:00

TARRYTOWN, N.Y., June 17, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that NASDAQ has halted trading of the company's common stock today. The Dermatologic and Ophthalmic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is meeting today to discuss the company's Biologics License Application (BLA) for EYLEA(TM), also known as VEGF Trap-Eye, for the treatment of the neovascular form of age-related macular degeneration (wet AMD)....

2011-06-15 08:00:00

SAN DIEGO, June 15, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it has received clearance from the Russian Ministry of Health and Social Development to commence a Phase 3 registration study for the Company's Generx(TM) (alferminogene tadenovec, Ad5FGF-4) biologic product candidate. Generx is a new and innovative DNA-based angiogenic therapy designed for the potential treatment of myocardial ischemia due to coronary artery disease. The Russian Health...

2011-06-10 06:37:43

(Ivanhoe Newswire) -- Proteins found in frog skin may be used to treat cancer, diabetes, stroke and transplant patients by regulating the growth of blood vessels, according to new research. Investigators from Queen's University Belfast identified two proteins that can be used to regulate angiogenesis, which is the process by which blood vessels grow in the body. They say this discovery could potentially help them develop new treatments for more than 70 major diseases and conditions that...

2011-06-07 15:12:56

Blocking two tiny molecules of RNA "“ a chemical cousin of DNA "“ appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have found. Their findings, available in the Proceedings of the National Academy of Sciences, suggest a potential strategy to treat age-related macular degeneration (AMD), a vascular eye disorder that affects nearly 2 million Americans and is a leading cause of blindness...

85401381d49ee0c286badb66b8225092
2011-06-07 14:25:00

Scientists at Queen's University Belfast have discovered that proteins in frog skins could be used to treat cancer, diabetes, stroke and transplant patients by regulating the growth of blood vessels. The researchers identified two proteins, or "peptides", which can be used in a controlled and targeted way to regulate "angiogenesis."  The discovery holds the potential to develop new treatments for more than seventy major diseases and conditions that affect over a billion people...

2011-06-06 18:38:00

MELBOURNE, Australia, June 6, 2011 /PRNewswire/ -- Circadian Technologies Limited (ASX: CIR) announced today the presentation of data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago USA associating resistance to Avastin® with increases in plasma VEGF-C and D concentrations. The poster presentation entitled "The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer (mCRC)" is available on...

2011-06-06 17:35:52

Scientists at the Walter and Eliza Hall Institute have discovered a key molecule needed to kill the blood vessels that supply tumors. The research team from the institute's Molecular Genetics of Cancer and Cancer and Haematology divisions found that for anti-cancer therapies that target tumor blood vessels to work the death- inducing molecule Bim is required. The finding could lead to improved anti-cancer treatments that are based on a two- or three-pronged attack on both the tumor and its...

2011-05-31 12:17:16

Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina "“ a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers. Researchers report that myeloid cells, blood cells involved in the immune system, use this molecular pathway to guide blood vessel patterning in the retina. Furthermore, in the same study researchers were able to reverse this pathway to accelerate the...

2011-05-29 12:00:00

CINCINNATI, May 29, 2011 /PRNewswire-USNewswire/ -- Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina - a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Researchers report that myeloid cells, blood cells involved in the immune system, use this molecular pathway to guide blood vessel...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related